在常见遗传风险变异的背景下分析microrna在精神分裂症中的作用。

Mads Engel Hauberg, Panos Roussos, Jakob Grove, Anders Dupont Børglum, Manuel Mattheisen
{"title":"在常见遗传风险变异的背景下分析microrna在精神分裂症中的作用。","authors":"Mads Engel Hauberg, Panos Roussos, Jakob Grove, Anders Dupont Børglum, Manuel Mattheisen","doi":"10.1001/jamapsychiatry.2015.3018","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>The recent implication of 108 genomic loci in schizophrenia marked a great advancement in our understanding of the disease. Against the background of its polygenic nature there is a necessity to identify how schizophrenia risk genes interplay. As regulators of gene expression, microRNAs (miRNAs) have repeatedly been implicated in schizophrenia etiology. It is therefore of interest to establish their role in the regulation of schizophrenia risk genes in disease-relevant biological processes.</p><p><strong>Objective: </strong>To examine the role of miRNAs in schizophrenia in the context of disease-associated genetic variation.</p><p><strong>Design, setting, and participants: </strong>The basis of this study was summary statistics from the largest schizophrenia genome-wide association study meta-analysis to date (83 550 individuals in a meta-analysis of 52 genome-wide association studies) completed in 2014 along with publicly available data for predicted miRNA targets. We examined whether schizophrenia risk genes were more likely to be regulated by miRNA. Further, we used gene set analyses to identify miRNAs that are regulators of schizophrenia risk genes.</p><p><strong>Main outcomes and measures: </strong>Results from association tests for miRNA targetomes and related analyses.</p><p><strong>Results: </strong>In line with previous studies, we found that similar to other complex traits, schizophrenia risk genes were more likely to be regulated by miRNAs (P < 2 × 10-16). Further, the gene set analyses revealed several miRNAs regulating schizophrenia risk genes, with the strongest enrichment for targets of miR-9-5p (P = .0056 for enrichment among the top 1% most-associated single-nucleotide polymorphisms, corrected for multiple testing). It is further of note that MIR9-2 is located in a genomic region showing strong evidence for association with schizophrenia (P = 7.1 × 10-8). The second and third strongest gene set signals were seen for the targets of miR-485-5p and miR-137, respectively.</p><p><strong>Conclusions and relevance: </strong>This study provides evidence for a role of miR-9-5p in the etiology of schizophrenia. Its implication is of particular interest as the functions of this neurodevelopmental miRNA tie in with established disease biology: it has a regulatory loop with the fragile X mental retardation homologue FXR1 and regulates dopamine D2 receptor density.</p>","PeriodicalId":58,"journal":{"name":"The Journal of Physical Chemistry ","volume":"85 19","pages":"369-77"},"PeriodicalIF":2.7810,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamapsychiatry.2015.3018","citationCount":"76","resultStr":"{\"title\":\"Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants.\",\"authors\":\"Mads Engel Hauberg, Panos Roussos, Jakob Grove, Anders Dupont Børglum, Manuel Mattheisen\",\"doi\":\"10.1001/jamapsychiatry.2015.3018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Importance: </strong>The recent implication of 108 genomic loci in schizophrenia marked a great advancement in our understanding of the disease. Against the background of its polygenic nature there is a necessity to identify how schizophrenia risk genes interplay. As regulators of gene expression, microRNAs (miRNAs) have repeatedly been implicated in schizophrenia etiology. It is therefore of interest to establish their role in the regulation of schizophrenia risk genes in disease-relevant biological processes.</p><p><strong>Objective: </strong>To examine the role of miRNAs in schizophrenia in the context of disease-associated genetic variation.</p><p><strong>Design, setting, and participants: </strong>The basis of this study was summary statistics from the largest schizophrenia genome-wide association study meta-analysis to date (83 550 individuals in a meta-analysis of 52 genome-wide association studies) completed in 2014 along with publicly available data for predicted miRNA targets. We examined whether schizophrenia risk genes were more likely to be regulated by miRNA. Further, we used gene set analyses to identify miRNAs that are regulators of schizophrenia risk genes.</p><p><strong>Main outcomes and measures: </strong>Results from association tests for miRNA targetomes and related analyses.</p><p><strong>Results: </strong>In line with previous studies, we found that similar to other complex traits, schizophrenia risk genes were more likely to be regulated by miRNAs (P < 2 × 10-16). Further, the gene set analyses revealed several miRNAs regulating schizophrenia risk genes, with the strongest enrichment for targets of miR-9-5p (P = .0056 for enrichment among the top 1% most-associated single-nucleotide polymorphisms, corrected for multiple testing). It is further of note that MIR9-2 is located in a genomic region showing strong evidence for association with schizophrenia (P = 7.1 × 10-8). The second and third strongest gene set signals were seen for the targets of miR-485-5p and miR-137, respectively.</p><p><strong>Conclusions and relevance: </strong>This study provides evidence for a role of miR-9-5p in the etiology of schizophrenia. Its implication is of particular interest as the functions of this neurodevelopmental miRNA tie in with established disease biology: it has a regulatory loop with the fragile X mental retardation homologue FXR1 and regulates dopamine D2 receptor density.</p>\",\"PeriodicalId\":58,\"journal\":{\"name\":\"The Journal of Physical Chemistry \",\"volume\":\"85 19\",\"pages\":\"369-77\"},\"PeriodicalIF\":2.7810,\"publicationDate\":\"2016-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1001/jamapsychiatry.2015.3018\",\"citationCount\":\"76\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Physical Chemistry \",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1001/jamapsychiatry.2015.3018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Physical Chemistry ","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamapsychiatry.2015.3018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 76

摘要

重要性:最近在精神分裂症中发现的108个基因组位点标志着我们对这种疾病的理解取得了巨大的进步。在其多基因性质的背景下,有必要确定精神分裂症风险基因如何相互作用。作为基因表达的调节因子,microRNAs (miRNAs)多次被认为与精神分裂症的病因有关。因此,在疾病相关的生物学过程中,确定它们在调节精神分裂症风险基因中的作用是有意义的。目的:在疾病相关遗传变异的背景下,研究mirna在精神分裂症中的作用。设计、环境和参与者:本研究的基础是迄今为止最大的精神分裂症全基因组关联研究荟萃分析的汇总统计数据(83 在52个全基因组关联研究的荟萃分析中有550个个体),完成于2014年,以及预测miRNA靶点的公开数据。我们研究了精神分裂症风险基因是否更有可能受到miRNA的调节。此外,我们使用基因集分析来鉴定作为精神分裂症风险基因调节因子的mirna。主要结局和指标:miRNA靶组的关联试验结果和相关分析。结果:与以往研究一致,我们发现与其他复杂性状相似,精神分裂症风险基因更可能受到mirna的调控(P结论及相关性:本研究为miR-9-5p在精神分裂症病因学中的作用提供了证据。它的含义是特别有趣的,因为这种神经发育miRNA的功能与已建立的疾病生物学相关:它与脆性X智力迟钝同源物FXR1有一个调节环,并调节多巴胺D2受体密度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants.

Importance: The recent implication of 108 genomic loci in schizophrenia marked a great advancement in our understanding of the disease. Against the background of its polygenic nature there is a necessity to identify how schizophrenia risk genes interplay. As regulators of gene expression, microRNAs (miRNAs) have repeatedly been implicated in schizophrenia etiology. It is therefore of interest to establish their role in the regulation of schizophrenia risk genes in disease-relevant biological processes.

Objective: To examine the role of miRNAs in schizophrenia in the context of disease-associated genetic variation.

Design, setting, and participants: The basis of this study was summary statistics from the largest schizophrenia genome-wide association study meta-analysis to date (83 550 individuals in a meta-analysis of 52 genome-wide association studies) completed in 2014 along with publicly available data for predicted miRNA targets. We examined whether schizophrenia risk genes were more likely to be regulated by miRNA. Further, we used gene set analyses to identify miRNAs that are regulators of schizophrenia risk genes.

Main outcomes and measures: Results from association tests for miRNA targetomes and related analyses.

Results: In line with previous studies, we found that similar to other complex traits, schizophrenia risk genes were more likely to be regulated by miRNAs (P < 2 × 10-16). Further, the gene set analyses revealed several miRNAs regulating schizophrenia risk genes, with the strongest enrichment for targets of miR-9-5p (P = .0056 for enrichment among the top 1% most-associated single-nucleotide polymorphisms, corrected for multiple testing). It is further of note that MIR9-2 is located in a genomic region showing strong evidence for association with schizophrenia (P = 7.1 × 10-8). The second and third strongest gene set signals were seen for the targets of miR-485-5p and miR-137, respectively.

Conclusions and relevance: This study provides evidence for a role of miR-9-5p in the etiology of schizophrenia. Its implication is of particular interest as the functions of this neurodevelopmental miRNA tie in with established disease biology: it has a regulatory loop with the fragile X mental retardation homologue FXR1 and regulates dopamine D2 receptor density.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells. A universal flu vaccine on the horizon. Mapping the hideouts and habits of bacteria in tumors. Prenatal treatment for Pompe's disease. Holding back progression of kidney disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1